Literature DB >> 2743286

Mass screening for cervical cancer in Taiwan from 1974 to 1984.

P Chou1, V Chen.   

Abstract

The cervical cancer screening program in Taiwan was carried out in two phases. This study focused on the first 10-year screening program. Univariate descriptive analysis with chi-square test and multivariate analysis with logistic regression were applied to find the significant risk factors related to cervical cancer in Taiwan. Comparison of Phase I and II screening revealed a cohort effect. The high examination rate in women aged 30 to 39 years in Phase I resulted in a drop in the suspicious rate in the 35 to 44 year age group in Phase II, and a decreasing trend of age-specific death rates from both cervical and uterine cancer in the 40 to 49 year age group based on all of the female population in Taiwan. In Phase II, an increasing trend in ratio of carcinoma in situ to invasive carcinoma was also found. These findings suggest that the 10-year screening program in Taiwan conducted by the Cancer Society of the Republic of China has been effective. How to increase the examination rate is the key issue in the control of cervical cancer in Taiwan.

Entities:  

Mesh:

Year:  1989        PMID: 2743286     DOI: 10.1002/1097-0142(19890815)64:4<962::aid-cncr2820640432>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Effectiveness of an intervention to increase Pap test screening among Chinese women in Taiwan.

Authors:  Su-I Hou; Maria E Fernandez; Elizabeth Baumler; Guy S Parcel
Journal:  J Community Health       Date:  2002-08

2.  Comparisons of Papanicolaou Utilization and Cervical Cancer Detection between Rural and Urban Women in Taiwan.

Authors:  Chiu-Ming Yang; Fung-Chang Sung; Chao-Song Hsue; Chih-Hsin Muo; Shu-Wei Wang; Shwn-Huey Shieh
Journal:  Int J Environ Res Public Health       Date:  2020-12-28       Impact factor: 3.390

3.  Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences.

Authors:  Y-Y Chen; S-L You; C-A Chen; L-Y Shih; S-L Koong; K-Y Chao; M-L Hsiao; C-Y Hsieh; C-J Chen
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.